Table 4.
PT | Infliximab | ||
---|---|---|---|
n | ROR | 95% CI | |
Pneumonia | 1254 | 5.04 | 4.75–5.34* |
Pneumocystis jirovecii pneumonia | 888 | 14.5 | 13.5–15.5* |
Interstitial lung disease | 799 | 1.78 | 1.66–1.92* |
Infusion related reaction | 679 | 58.6 | 53.4–64.3* |
Herpes zoster | 412 | 6.82 | 6.17–7.55* |
Sepsis | 409 | 3.79 | 3.43–4.19* |
Pulmonary tuberculosis | 384 | 32.2 | 28.7–36.1* |
Pyrexia | 381 | 1.62 | 1.47–1.8* |
Pneumonia bacterial | 323 | 10.5 | 9.37–11.8* |
Lymphoma | 306 | 18.4 | 16.3–20.8* |
Note: *Signal detected.
Abbreviations: CI, confidence interval; PT, preferred terms; ROR, reporting odds ratio.